Catestatin as a New Prognostic Marker in Stable Patients with Heart Failure with Reduced Ejection Fraction in Two-Year Follow-Up

Background and Purpose. The main goal of the study was to assess the usefulness of plasma concentrations of catestatin as a predictor of a composite endpoint (CE): unplanned hospitalization and death for all causes in patients with HFrEF in the midterm follow-up. Experimental Approach. The study gro...

Descripción completa

Detalles Bibliográficos
Autores principales: Wołowiec, Łukasz, Rogowicz, Daniel, Banach, Joanna, Gilewski, Wojciech, Sinkiewicz, Władysław, Grześk, Grzegorz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556099/
https://www.ncbi.nlm.nih.gov/pubmed/33082887
http://dx.doi.org/10.1155/2020/8847211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556099/
https://www.ncbi.nlm.nih.gov/pubmed/33082887
http://dx.doi.org/10.1155/2020/8847211

Ejemplares similares